US Patent 10781267 Methods of treating by administering anti-kit antibodies
Patent 10781267 was granted and assigned to Celldex Therapeutics on September, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 22 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
107812670
Date of Patent
September 22, 2020
0Patent Application Number
162210020
Date Filed
December 14, 2018
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 2 Apr, 2023
Golden AI
Infobox
Edits on 26 Sep, 2022
Golden AI
Infobox
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Feb, 2022
Golden AI
Edits made to:
Infobox (+12 properties)
US Patent 10781267 Methods of treating by administering anti-kit antibodies
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10781267
Date of patent
September 22, 2020
Patent application number
16221002
Date Filed
December 14, 2018
Patent citations
Patent primary examiner
Find more entities like US Patent 10781267 Methods of treating by administering anti-kit antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.